Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
EBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Net Income towards Common Stockholders (2016 - 2025)

Lifecore Biomedical, Inc. \De\ (LFCR) has 16 years of Net Income towards Common Stockholders data on record, last reported at -$2.0 million in Q2 2025.

  • For Q2 2025, Net Income towards Common Stockholders rose 71.1% year-over-year to -$2.0 million; the TTM value through May 2025 reached -$44.4 million, down 527.31%, while the annual FY2025 figure was -$44.4 million, 469.26% down from the prior year.
  • Net Income towards Common Stockholders reached -$2.0 million in Q2 2025 per LFCR's latest filing, up from -$17.4 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $15.6 million in Q1 2024 and bottomed at -$25.2 million in Q1 2023.
  • Average Net Income towards Common Stockholders over 5 years is -$4.7 million, with a median of -$2.9 million recorded in 2021.
  • The widest YoY moves for Net Income towards Common Stockholders: up 162.09% in 2024, down 36162.5% in 2024.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at $1.3 million in 2021, then plummeted by 383.41% to -$3.6 million in 2022, then skyrocketed by 99.33% to -$24000.0 in 2023, then tumbled by 36162.5% to -$8.7 million in 2024, then soared by 76.48% to -$2.0 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were -$2.0 million in Q2 2025, -$17.4 million in Q1 2025, and -$8.7 million in Q4 2024.